Nchi: Indonesia
Lugha: Kiindonesia
Chanzo: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
CINCHOCAINE HYDROCHLORIDE; POLICRESULEN
PHAROS INDONESIA - Indonesia
CINCHOCAINE HYDROCHLORIDE; POLICRESULEN
50/10 MG PER G
SALEP
DUS, TUBE @ 20 G
PHAROS INDONESIA - Indonesia
2019-07-15
FAKTU SALEP COMPOSITION ® . FAKTU OINTMENT 1 g contains 50 mg of policresulen and 10 mg of cinchocaine hydrochloride. ACTION AND USES ® FAKTU for use in the treatment of haemmorrhoidal conditions is available as ointment. Presentation forms contain policresulen and the local anesthetic cinchocaine as active substances. The astringent, bactericidal and ® haemostatic actions of FAKTU have proved useful in the therapy of ® anorectal diseases. The essential active principle of FAKTU : policresulen exerts a selective action upon necrotic tissue without affecting healthy epithelium. Pathologically changed tissue is coagulated to be subsequently cast off. Bleedings are promptly controlled, since a protective film is formed upon wound areas, consisting of denatured protein and anal capillaries are constricted and closed. Oozing and itching are removed. Regeneration is further promoted by the hyperemic effect induced by the preparations. The bactericidal effect of ® FAKTU prevents or controls inflammatory processes. Cinchocaine has shown to be useful in proctology, providing relief of pain and itching. ® FAKTU quickly eliminates bleeding, oozing, and itching in haemmorrhoidal diseases and other anorectal disorders, prevents inflammation and stimulates the regeneration of the affected tissue. INDICATIONS . Haemmorrhoids ® FAKTU ointment for internal and external use, especially those associated with inflammatory conditions or bleeding. . Anal fissures DOSAGE AND ADMINISTRATION OINTMENT : The ointment is applied 2 - 3 times daily to the affected area. Rectal insertion of ointment requires prior evacuation of bowel; use enclosed applicator for introduction. CONTRAINDICATION ® FAKTU must not be used in case of hypersensitivity to cinchocaine or to ® any of the excipients. FAKTU contain phopholipids from soya beans. In case of hypersensivity to soya or peanuts. UNDESIRABLE EFFECTS The following frequency convention is used in the evaluation of side effects: Very common : more than 1 in 10 patients treated. Uncommon : Soma hati kamili